S. 945 Introduces New Disclosure Requirements for U.S.-Listed Chinese Companies and Possible Delisting for Non-Compliance
Jinsong (Jeff) Zhang, a partner in Orrick’s Beijing and New York offices, is a trusted advisor to international and Chinese investors and corporates on their transactional, regulatory and compliance matters. His work spans a variety of industries, including financial services, technology (automotive technology and mobility, life sciences, and Fintech), as well as energy and infrastructure.
Being recognized by Legal 500 Asia Pacific, clients have praised Jeff as a practitioner “who is dedicated to serving his clients and is able to leverage off the firm’s global network to provide services in specialized areas”.
Jeff’s practice focuses on China-related inbound and outbound mergers and acquisitions and private equity transactions. He has extensive experience with share and asset acquisitions, growth capital and buyout transactions as well as tender offers, privatizations, restructurings, spin-offs, strategic alliances and joint ventures.
In addition, Jeff advises multinationals, financial institutions and private equity funds on their general corporate, capital markets and regulatory compliance matters.
Prior to joining Orrick, Jeff was a partner at the New York office of an international law firm. Earlier in his career, Jeff practiced in New York, Hong Kong, and mainland China with two major international law firms, and also served as the Head of Legal and Compliance of the U.S. operations of a leading Chinese investment bank, where he gained tremendous experience in helping Chinese clients navigate regulatory and compliance issues in the U.S.
Jeff serves on the International Advisory Board of Duke Law School, where he was also appointed as a Senior Lecturing Fellow. In his leisure time, Jeff serves on a volunteer basis as the Chief Legal Officer of The Chinese Finance Association (TCFA), a non-profit professional organization headquartered in New York with more than 7,000 members globally.
M&A and Private Equity
Automotive Technology & Mobility
Life Sciences & Healthcare
Industrial, Energy & Infrastructure
Tender Offer and Going-private Transactions